25

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) went up by 0.37% from its latest closing price when compared to the 1-year high value of $17.74 and move down -61.71%, while IRWD stocks collected +0.83% of gains with the last five trading sessions.

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Worth an Investment?

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) The 36 Months beta value for IRWD stocks is at 1.75, while 4 of the analysts out of 11 who provided ratings for Ironwood Pharmaceuticals, Inc. stocks as a “buy” while 0 as overweight, 7 rated it as hold and 0 as sell. The average price we get from analysts is $14.45 which is $3.48 above current price. IRWD currently has a short float of 11.23% and public float of 150.02M with average trading volume of 1.47M shares.

IRWD Market Performance

IRWD stocks went up by 0.83% for the week, with the monthly jump of 11.94% and a quarterly performance of -5.51%, while its annual performance rate touched -25.91%. The simple moving average for the period of the last 20 days is -0.11% for IRWD stocks with the simple moving average of -6.99% for the last 200 days.

Analysts’ Opinion on Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Many brokerage firms have already submitted their reports for IRWD stocks, with Morgan Stanley repeating the rating for IRWD shares by setting it to “Equal-Weight”. The predicted price for IRWD socks in the upcoming period according to Morgan Stanley is $164 based on the research report published on March 27, 2019.

H.C. Wainwright, on the other hand, stated in their research note that they expect to see IRWD stock at the price of $14. The rating they have provided for IRWD stocks is “Neutral” according to the report published on February 25, 2019.

JP Morgan gave “ Neutral” rating to IRWD stocks, setting the target price at $14 in the report published on January 24, 2019.

IRWD Stocks -2.74% Far from 50 Day Moving Average

After a stumble in the market that brought IRWD to its low price for the period of the last 52 weeks, Ironwood Pharmaceuticals, Inc. was unable to take a rebound, for now settling with -38.18% of loss for the given period.

The stock volatility was left at 4.59%, however, within the period of a single month, the volatility rate increased by 3.37%, while the shares surge at the distance of +11.94% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by -10.89% lower at the present time.

In the course of the last 5 trading sessions, IRWD went up by +0.83%, which changed the moving average for the period of 200 days to the total of -40.96% of losses for the stock in comparison to the 20-day moving average settled at $11.04. In addition, Ironwood Pharmaceuticals, Inc. saw 26.51% in overturn over the period of a single year with a tendency to cut further gains.

IRWD Stock Insider Trading

Reports are indicating that there were more than several insider trading activities at Ironwood Pharmaceuticals, Inc. (IRWD), starting from OLANOFF LAWRENCE S, who sold 2,000 shares at the price of $11.25 back on Jun 05. After this action, Rushing now owns 58,259 shares of Ironwood Pharmaceuticals, Inc., valued at $22,500 with the latest closing price.

McHugh Julie, the Director of Ironwood Pharmaceuticals, Inc., sold 1,500 shares at the value of $11.26 during a trade that took place back on Jun 05, which means that McHugh Julie is holding 109,337 shares at the value of $16,890 based on the most recent closing price.

IRWD Stock Fundamentals

The current profitability levels are settled at -29.50 for the present operating margin and +88.21 for gross margin. The net margin for Ironwood Pharmaceuticals, Inc. stands at -81.46. Total capital return value is set at -32.59, while invested capital returns managed to touch -98.07. Equity return holds the value 176.90%, with -69.00% for asset returns.

The value for Enterprise to Sales is 5.66 with debt to enterprise value settled at 0.23. The receivables turnover for Ironwood Pharmaceuticals, Inc. is 4.25 with the total asset turnover at the value of 0.74. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.23.